Effects of chronic amiodarone therapy on ventricular tachycardia induced by programmed ventricular stimulation. 1987

L A DiCarlo, and F Morady, and M de Buitleir, and J M Baerman, and L Schurig, and T Annesley

Several studies have reported upon the inducibility of ventricular tachycardia (VT) with programmed ventricular stimulation (PVS) during chronic amiodarone therapy; however, few studies have systematically described and compared the morphology, duration, and cycle length of VT induced by PVS before and after amiodarone. In this study, 26 patients with symptomatic VT or ventricular fibrillation were evaluated by PVS by means of one to three extrastimuli (ES) before treatment and after 2 months of amiodarone therapy. Before amiodarone, sustained unimorphic VT was induced in 21 patients (group A) and symptomatic, nonsustained VT was induced in five patients (group B). After 65 +/- 8 days of amiodarone (total dose 64.5 +/- 8.9 gm, mean +/- S.D.), 15 of 21 patients (71%) in group A had sustained VT, five patients (24%) had nonsustained VT, and one patient had no VT induced. Four of five patients (80%) in group B had sustained VT and one patient had no VT induced. VT was induced by the same or by fewer number of ES in 79% of cases. When the morphologies of the VT induced before and after amiodarone were compared, the morphology of VT induced after amiodarone was the same in only 8 of 24 patients (33%), unimorphic but different in 14 patients (58%), and polymorphic in the remaining two patients. No correlation was found between the serum concentrations of amiodarone, desethylamiodarone, tetraiodothyronine, triiodothyronine, or reverse triiodothyronine, and similarities or differences in VT morphology, VT cycle length, or the relative number of ES required to induce VT after treatment with amiodarone.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D004594 Electrophysiology The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000638 Amiodarone An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance. Amiobeta,Amiodarex,Amiodarona,Amiodarone Hydrochloride,Amiohexal,Aratac,Braxan,Corbionax,Cordarex,Cordarone,Kordaron,L-3428,Ortacrone,Rytmarone,SKF 33134-A,Tachydaron,Trangorex,Hydrochloride, Amiodarone,L 3428,L3428,SKF 33134 A,SKF 33134A
D013610 Tachycardia Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia. Tachyarrhythmia,Tachyarrhythmias,Tachycardias

Related Publications

L A DiCarlo, and F Morady, and M de Buitleir, and J M Baerman, and L Schurig, and T Annesley
January 1993, Journal of the American College of Cardiology,
L A DiCarlo, and F Morady, and M de Buitleir, and J M Baerman, and L Schurig, and T Annesley
January 1993, Journal of the American College of Cardiology,
L A DiCarlo, and F Morady, and M de Buitleir, and J M Baerman, and L Schurig, and T Annesley
November 1993, European heart journal,
L A DiCarlo, and F Morady, and M de Buitleir, and J M Baerman, and L Schurig, and T Annesley
October 1982, Annals of internal medicine,
L A DiCarlo, and F Morady, and M de Buitleir, and J M Baerman, and L Schurig, and T Annesley
February 1985, The American journal of cardiology,
L A DiCarlo, and F Morady, and M de Buitleir, and J M Baerman, and L Schurig, and T Annesley
November 1989, The American journal of cardiology,
L A DiCarlo, and F Morady, and M de Buitleir, and J M Baerman, and L Schurig, and T Annesley
January 1979, Annales de cardiologie et d'angeiologie,
L A DiCarlo, and F Morady, and M de Buitleir, and J M Baerman, and L Schurig, and T Annesley
January 1983, American heart journal,
L A DiCarlo, and F Morady, and M de Buitleir, and J M Baerman, and L Schurig, and T Annesley
October 1989, Israel journal of medical sciences,
L A DiCarlo, and F Morady, and M de Buitleir, and J M Baerman, and L Schurig, and T Annesley
June 1981, Cardiovascular diseases,
Copied contents to your clipboard!